Hørsholm – June 26, 2007 7TM Pharma A/S announces that the company has been granted patents in the UK covering the use of the drug candidates Obinepitide and TM30339, both for the treatment of obesity. Obinepitide is a close analogue of two natural hormones, each with different mechanisms of action, which are incorporated into one compound, Obinepitide. TM30339 is an analogue of the natural hormone Pancreatic Polypeptide (PP), which is released in connection with meals.
